Compare CDNA & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | AVAH |
|---|---|---|
| Founded | 1998 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.9B |
| IPO Year | 2014 | 2021 |
| Metric | CDNA | AVAH |
|---|---|---|
| Price | $19.08 | $8.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $26.67 | $10.19 |
| AVG Volume (30 Days) | 778.2K | ★ 1.1M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.22 | 0.37 |
| Revenue | $357,998,000.00 | ★ $2,290,591,000.00 |
| Revenue This Year | $14.11 | $20.08 |
| Revenue Next Year | $11.75 | $7.12 |
| P/E Ratio | ★ $15.80 | $22.75 |
| Revenue Growth | 14.46 | ★ 15.48 |
| 52 Week Low | $10.96 | $3.67 |
| 52 Week High | $25.95 | $10.32 |
| Indicator | CDNA | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 53.43 | 36.40 |
| Support Level | $19.01 | $8.56 |
| Resistance Level | $20.61 | $9.27 |
| Average True Range (ATR) | 0.78 | 0.26 |
| MACD | -0.19 | -0.07 |
| Stochastic Oscillator | 17.62 | 12.79 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.